CompletedPhase 2

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Belgium, Germany60 participantsStarted 2007-02

Plain-language summary

A multicenter study to compare multiple doses of intravitreal microplasmin for non-surgical PVD induction for treatment of patients with vitreomacular traction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \>\_ 18 years of age with vitreomacular traction Exclusion Criteria: * PVD present at baseline * Certain vitreoretinal conditions including proliferative disease, rhegmatogenous retinal detachment, and proliferative vitreoretinopathy (PVR) * Vitreous hemorrhage * Patients who have had a vitrectomy in the study eye at any time

What they're measuring

Proportion of Subjects With Total PVD at the First Day 14 Post-injection Visit (Vitreous Detachment to the Equator) as Determined by Masked Central Reading Center (CRC) Evaluation of B-scan Imaging.

Timeframe: Day 14

Trial details

NCT IDNCT00435539

SponsorThromboGenics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-01

Results submitted2013-07-04

View on ClinicalTrials.gov More Vitreomacular Traction trials